logo
JLR to begin car assembly in Tamil Nadu by 2026; Tata Motors delays Avinya EV launch

JLR to begin car assembly in Tamil Nadu by 2026; Tata Motors delays Avinya EV launch

Time of India10 hours ago

British auto maker
Jaguar Land Rover
(JLR) will start assembling its luxury vehicles from completely knocked down (CKD) kits at its upcoming factory in Tamil Nadu by early 2026, said senior executives at parent
Tata Motors
on Tuesday. However,
Tata Motors
has deferred the launch of its flagship Avinya brand of
electric vehicles
(EVs) by a year due to engineering and feasibility challenges, the executives told a media briefing.
JLR plans to invest about Rs 9,000 crore over five years in Tamil Nadu, marking a strategic realignment for the company's domestic manufacturing footprint. The automaker will initially assemble the
Range Rover Evoque
and Velar SUVs, with a planned annual capacity of 30,000 units.
Eventually, it will also see JLR move operations from Tata Motors' existing facility in Pune to Ranipet, enabling better scale and logistical synergies, said PB Balaji, Group CFO, Tata Motors.
'This move gives us a scalable, future-ready base as JLR expands its portfolio in India,' said Balaji. The site is also expected to serve as a potential base for Tata's premium EV production, including vehicles under the Avinya brand, making it a critical hub for both Tata and JLR operations, he said.
The announcement comes amid expectations of the
India-UK Free Trade Agreement
(FTA) easing tariffs on imported auto parts and fully-built vehicles. While the FTA may improve the economics of importing cars, local CKD assembly is viewed as a strategic hedge to control costs and keep regulatory flexibility.
Tata Motors, however, is now looking at a 2026 timeline—instead of 2025—for the market debut of Avinya, its much-anticipated premium electric offering.
'In 2022, we were optimistic that we could bring Avinya to market in two-and-a-half years,' said Shailesh Chandra, MD – Tata Motors Passenger Vehicles and Tata Passenger Electric Mobility. 'But feasibility issues in certain subsystems and architectural layers meant we needed more engineering time. Some blind spots emerged during execution, and the industrialisation process has taken longer than expected.'
Chandra clarified that Avinya will be launched as a standalone
premium EV brand
, without overt Tata branding, aimed at tapping global demand for high-end electric mobility.
Meanwhile, he also flagged policy concerns, especially state-level incentives being extended to hybrid vehicles. 'These distort the market and delay EV adoption,' Chandra said. 'There needs to be policy clarity and consistency. Incentives that favour hybrids over EVs risk undermining the national electrification vision.'
Commenting on the impact of geopolitical tensions and tariff wars on JLR, Balaji said Tata Motors is stepping up efforts to manage global headwinds for JLR by activating demand in key markets and launching a cost-cutting drive to offset tariff-related pressures.
'We're dialling up market activation around Range Rover, Range Rover Sport, and Defender to tap recovery in the UK and stable demand in the US, Europe, and the Middle East,' he said.
On the cost side, JLR continues to face 27.5% import tariffs in the US, with duties also applying to vehicles sourced from its Slovakia plant.
To mitigate margin pressure, Tata Motors has started a cost-out programme aimed at restoring JLR's 10% EBIT margin over the next 12–18 months.
Balaji ruled out any immediate plans for a US manufacturing site, saying JLR would avoid overextending itself in uncertain trade conditions.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Arisinfra Solutions IPO listing today: Flat GMP suggests muted debut
Arisinfra Solutions IPO listing today: Flat GMP suggests muted debut

Economic Times

time31 minutes ago

  • Economic Times

Arisinfra Solutions IPO listing today: Flat GMP suggests muted debut

With the IPO price fixed at Rs 222 per share, the estimated listing price remains at Rs 222, reflecting a 0% expected gain or discount based on the latest GMP data. Synopsis Arisinfra Solutions is set to list on the BSE and NSE with muted expectations, indicated by a grey market premium of Rs 0, despite strong anchor backing. The IPO, priced at Rs 222, saw modest subscription rates across retail, QIB, and NII categories. While the company reported a recent profit after previous losses, the market remains cautious. Infrastructure-tech firm Arisinfra Solutions is all set to debut on the bourses today following a three-day IPO bidding window that closed on June 20. However, ahead of its listing on the BSE and NSE mainboards, the stock is showing no grey market premium (GMP), currently quoted at Rs 0, indicating muted listing expectations despite the company's strong fundamentals and marquee anchor backing. ADVERTISEMENT With the IPO price fixed at Rs 222 per share, the estimated listing price remains at Rs 222, reflecting a 0% expected gain or discount based on the latest GMP data. This neutral sentiment may be reflective of broader market volatility, valuation concerns, or near-term demand-supply dynamics. The issue was a pure fresh equity sale of 2.25 crore shares, aggregating to Rs 499.60 crore, with no offer-for-sale component. The company raised Rs 224.82 crore from anchor investors a day before the opening, with strong institutional participation. The issue saw modest retail interest with 5.90 times subscription in the retail category. QIBs subscribed 1.5 times, and NIIs came in at 3.32 times, taking the total subscription to 2.80 times in 2021, Arisinfra Solutions is a B2B procurement and financial platform that caters to the construction materials supply chain. The company services over 2,100 customers across 960+ PIN codes, dealing in materials such as steel, cement, aggregates, RMC, chemicals, and walling solutions. ADVERTISEMENT Arisinfra also operates a subsidiary, ArisUnitern Re Solutions, offering consultancy and advisory services tailored to real estate a loss-making track record until FY24, the company reported a profit of Rs 6.53 crore in the nine months ending December 2024, along with an EBITDA of Rs 39.88 crore, signalling a possible turnaround. ADVERTISEMENT The zero GMP suggests that the market is taking a cautious stance ahead of listing. That said, the company's growth trajectory, institutional confidence, and improving financial performance could still drive interest post-listing, especially if the broader market supports a rerating. (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times) (You can now subscribe to our ETMarkets WhatsApp channel) Nikita Papers IPO opens on May 27, price band set at Rs 95-104 per share Nikita Papers IPO opens on May 27, price band set at Rs 95-104 per share Why gold prices could surpass $4,000: JP Morgan's bullish outlook explained Why gold prices could surpass $4,000: JP Morgan's bullish outlook explained Cyient shares fall over 9% after Q4 profit declines, core business underperforms Cyient shares fall over 9% after Q4 profit declines, core business underperforms L&T Technology Services shares slide 7% after Q4 profit dips L&T Technology Services shares slide 7% after Q4 profit dips Trump-Powell standoff puts U.S. Rate policy in crosshairs: Who will blink first? Trump-Powell standoff puts U.S. Rate policy in crosshairs: Who will blink first? SEBI warns of securities market frauds via YouTube, Facebook, X and more SEBI warns of securities market frauds via YouTube, Facebook, X and more API Trading for All: Pi42 CTO Satish Mishra on How Pi42 is Empowering Retail Traders API Trading for All: Pi42 CTO Satish Mishra on How Pi42 is Empowering Retail Traders Security, transparency, and innovation: What sets Pi42 apart in crypto trading Security, transparency, and innovation: What sets Pi42 apart in crypto trading Bitcoin, Ethereum, or Altcoins? How investors are structuring their crypto portfolios, Avinash Shekhar explains Bitcoin, Ethereum, or Altcoins? How investors are structuring their crypto portfolios, Avinash Shekhar explains The rise of Crypto Futures in India: Leverage, tax efficiency, and market maturity, Avinash Shekhar of Pi42 explains NEXT STORY

Influx Healthtech IPO debut today: GMP signals moderate listing buzz
Influx Healthtech IPO debut today: GMP signals moderate listing buzz

Economic Times

time31 minutes ago

  • Economic Times

Influx Healthtech IPO debut today: GMP signals moderate listing buzz

As per the latest update, the grey market premium (GMP) stands at Rs 20, translating to an expected listing price of Rs 116 per share, over the IPO price of Rs 96 — a potential 20.83% gain on listing. Synopsis Influx Healthtech is set to debut on the NSE SME platform today after its Rs 58.57 crore IPO. The IPO price was fixed at Rs 96 per share. The company, a CDMO established in 2020, offers manufacturing and product development services for nutraceuticals, cosmetics, and other healthcare products, operating from facilities in Thane, Maharashtra. Healthcare-focused contract manufacturer Influx Healthtech is set to make its market debut on the NSE SME platform today. The Rs 58.57 crore IPO, which concluded its bidding on June 20, has entered the final leg of its public issue journey, with allotments wrapped up and shares ready for listing. ADVERTISEMENT As per the latest update, the grey market premium (GMP) stands at Rs 20, translating to an expected listing price of Rs 116 per share, over the IPO price of Rs 96 — a potential 20.83% gain on listing. The IPO comprised a fresh issue of 50 lakh shares worth Rs 48 crore and an offer for sale (OFS) of 11 lakh shares worth Rs 10.56 crore, offering a total of 61,00,800 shares. The IPO price was fixed at Rs 96 per share. The anchor portion attracted Rs 16.67 crore, with shares allocated to institutional investors a day before the issue in 2020, Influx Healthtech is a CDMO (Contract Development and Manufacturing Organization) providing end-to-end manufacturing and product development services for nutraceuticals, cosmetics, personal care, ayurvedic, veterinary, and homecare products. ADVERTISEMENT Operating out of three modern facilities in Thane, Maharashtra, the company boasts an extensive portfolio including gummies, capsules, powders, skincare products, herbal supplements, and veterinary feed formulations. It serves nutraceutical, cosmetic, and healthcare clients, handling everything from formulation and R&D to regulatory support and company currently employs 163 people and continues to expand its product capabilities and client reach, focusing on innovation and scalability in fast-growing consumer health segments. ADVERTISEMENT Influx Healthtech posted a revenue of Rs 104.99 crore in FY25, up 5% year-on-year, while PAT rose 19% to Rs 13.37 crore. It maintains a robust ROE of 36.98%, EBITDA margin of 19.62%, and negligible debt. ADVERTISEMENT (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times) (You can now subscribe to our ETMarkets WhatsApp channel) Nikita Papers IPO opens on May 27, price band set at Rs 95-104 per share Nikita Papers IPO opens on May 27, price band set at Rs 95-104 per share Why gold prices could surpass $4,000: JP Morgan's bullish outlook explained Why gold prices could surpass $4,000: JP Morgan's bullish outlook explained Cyient shares fall over 9% after Q4 profit declines, core business underperforms Cyient shares fall over 9% after Q4 profit declines, core business underperforms L&T Technology Services shares slide 7% after Q4 profit dips L&T Technology Services shares slide 7% after Q4 profit dips Trump-Powell standoff puts U.S. Rate policy in crosshairs: Who will blink first? Trump-Powell standoff puts U.S. Rate policy in crosshairs: Who will blink first? SEBI warns of securities market frauds via YouTube, Facebook, X and more SEBI warns of securities market frauds via YouTube, Facebook, X and more API Trading for All: Pi42 CTO Satish Mishra on How Pi42 is Empowering Retail Traders API Trading for All: Pi42 CTO Satish Mishra on How Pi42 is Empowering Retail Traders Security, transparency, and innovation: What sets Pi42 apart in crypto trading Security, transparency, and innovation: What sets Pi42 apart in crypto trading Bitcoin, Ethereum, or Altcoins? How investors are structuring their crypto portfolios, Avinash Shekhar explains Bitcoin, Ethereum, or Altcoins? How investors are structuring their crypto portfolios, Avinash Shekhar explains The rise of Crypto Futures in India: Leverage, tax efficiency, and market maturity, Avinash Shekhar of Pi42 explains NEXT STORY

HDB Financial raises Rs 3,369 crore from anchor investors ahead of IPO
HDB Financial raises Rs 3,369 crore from anchor investors ahead of IPO

Economic Times

time31 minutes ago

  • Economic Times

HDB Financial raises Rs 3,369 crore from anchor investors ahead of IPO

HDB Financial Services has raised Rs 3,369 crore from anchor investors ahead of its initial public offering (IPO), which opens today and closes on June 27. The company allocated 4.55 crore shares at Rs 740 apiece, the upper end of the price band, to anchor investors. ADVERTISEMENT India's largest insurer, the Life Insurance Corporation of India (LIC), received the largest allocation, securing 6.53% of the anchor portion, valued at around Rs 220 crore. The company also allotted 1.93 crore shares to 22 domestic mutual funds through 65 schemes, representing 42% of the anchor book. Participants included ICICI Prudential, SBI Mutual Fund, Kotak Mahindra AMC, Axis Mutual Fund, Aditya Birla Sun Life, Motilal Oswal, and HSBC MF, among others. Major global investors such as BlackRock, Goldman Sachs, Baillie Gifford Pacific Fund, Government Pension Fund Global, Templeton, and the Abu Dhabi Investment Authority (ADIA) also participated. Also read: Catch all latest updates on HDB Financial Services IPO ADVERTISEMENT The IPO comprises a fresh issue of Rs 2,500 crore and an offer for sale (OFS) of Rs 10,000 crore by HDFC Bank, which currently holds a 95.5% stake in the company. The price band is set at Rs 700–740 per share. The grey market premium (GMP) ahead of the issue was around Rs 74, indicating a 10% the upper band, the issue values the company at 3.7 times FY25 post-issue book value. Analysts consider the valuation reasonable, given HDB Financial's performance and HDFC Bank's backing. ADVERTISEMENT HDB Financial is one of the leading NBFCs in the country with a loan book of Rs 1.06 lakh crore as of March 31, 2025. The company reported a net profit of Rs 2,176 crore for FY25, a significant rise from Rs 1,359 crore a year gross non-performing assets (GNPA) stood at 2.49%, while net NPA came in at 1.38%, showing healthy asset quality for a retail-focused NBFC. ADVERTISEMENT Read more: LG rewires strategy before hitting IPO switch The company has a pan-India presence with over 1,700 branches across 1,200 cities and towns, and serves over 1.9 crore customers. Its business spans secured and unsecured personal loans, gold loans, and lending to small and medium enterprises (SMEs). ADVERTISEMENT At the upper end of the price band, the IPO values HDB Financial at a post-issue price-to-book value of 3.7 times FY25 estimates. Analysts view this as reasonable, considering its performance and HDFC Bank's brand houses have given a thumbs up to the IPO. SBI Securities, Ventura Securities, and Anand Rathi all issued 'Subscribe' calls, citing strong fundamentals, stable asset quality, and long-term growth prospects. 'We believe the IPO is fairly priced given the company's improving profitability, robust risk management and capital adequacy,' Ventura said in its Rathi added, 'The IPO offers an opportunity to invest in a high-quality, retail-focused NBFC that benefits from HDFC Bank's reach, reputation and systems. The improving return ratios and earnings visibility make it a compelling long-term bet.' Read more: HDB Financial plans to raise Rs 12,500 crore amidst rising loan growth and regulatory challenges The proceeds from the fresh issue will be used to augment HDB Financial's capital base and support its future lending activities. The OFS component will go to the selling shareholder, HDFC Bank. Post the IPO, the parent bank's stake will reduce significantly, aligning with regulatory company is expected to list on both NSE and BSE in the first week of July. (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times) (You can now subscribe to our ETMarkets WhatsApp channel)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store